Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What has happened to this board? It is not the vital site it once was!

With the proposed Rule 14a-11 the subject of a court ruling it is not yet in force, and even it it was, PTSC with a Market Cap on the relevant dates of under $75 million would be exempt for three years.

This leaves the existing Rule 14a-8, which allows management to exclude a proposal if it “relates to a nomination or an election for membership on the company’s board of directors"

I therefore stand by my original statement that any talk of nomination for the next meeting falsely raises expectations. Under either Rule, it will be at least three years before a shareholder nomination is viable.

Please have the last word and prove the above facts wrong.

.

.

.

Be well

Share
New Message
Please login to post a reply